Yet experts say we may be entering the golden years of Parkinson’s research. At the University of Florida, Parkinson’s disease patient Russell Price undergoes surgery to implant a deep brain ...

The study aims to determine whether a composite clinical motor score, combining the Movement Disorders Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) III motor examination score, Purdue ...

Forbes contributors publish independent expert analyses and insights. Daryl Austin is a Utah-based reporter who covers health and wellness.

Parkinson’s disease is a neurodegenerative disorder that causes a gradual loss of brain nerve cells, which produce a chemical ...

The Phase I clinical trial aims to evaluate the safety, tolerability, and preliminary efficacy of UX-DA001 in patients with Parkinson's disease. On March 1, 2025, Dr. Li Dianyou, Director of the ...

Current therapies for Parkinson’s disease (PD) have robust effects on symptoms (until the later stages of the disorder), but none has been proven to alter the course of the disease. Previous ...

FRANKLIN, Tenn. (WKRN) – A clinical trial is underway in Middle Tennessee testing whether a pill can help reduce involuntary muscle movements in people with Parkinson’s disease. According to ...

Isabella Cueto covers the leading causes of death and disability: chronic diseases. Her focus includes autoimmune conditions and diseases of the lungs, kidneys, liver (and more). She writes about ...

ABSTRACT: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the selective degeneration of dopaminergic neurons in the substantia nigra pars compacta, resulting in a ...

ABSTRACT: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the selective degeneration of dopaminergic neurons in the substantia nigra pars compacta, resulting in a ...